stabil biz lower-than-expect
posit view core fundament specif growth
see specialti volum relationship well
core margin improv gener busi pharmedium issu
persist impact earn power believ fulli bake
stock absent increment regulatori issu gener rx price
trend in-lin expect yesterday sell-off seem unwarr
thesi summari stabl improv fundament maintain hold
valuat though see potenti nt stock upsid posit view
fundament specif margin improv see gener also
believ guidanc adjust reflect continu issu pharmedium came
investor expect core busi perform off-set drag
lost margin dollar segment overhang/risk issu start
dissip though still drag ebit growth given adequ
incorpor current gener price deflat stabl rate price declin guidanc
fact compani signific contract repric come
believ yesterday pressur stock revers nt said maintain
hold valuat stock trade close histor rel
tell us fundament busi rel
good includ gener head week earn releas investor
anticip guidanc cut relat pharmedium management adjust project
end smaller expect core segment actual perform ahead
plan volum margin show improv driven specialti onboard
store moder stabil gener price deflat
note maintain expect gener deflat year management
comment meaning contract repricings/renew come
combin point stabl outlook even
lower pt reflect ep adjust pharmedium declin
valuat benchmark pe/g revis pt deriv appli histor
pe/g ratio discount vs lt ep growth assumpt risk
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
maintain hold rate given
belief compani fairli modest growth outlook
coupl downward adjust
ep estim limit stock upsid
magnitud number brand drug price increas
sell-sid gener deflat continu moder
move brand inflat remain high
abc specialti distribut busi along mwi
segment busi help off-set nt
capit deploy primarili focus capital-expenditure
strateg buyback provid sharehold
discount pe/g pt
sell-sid gener deflat moder expect
abl continu leverag wbad yield
improv gener margin profit dollar
brand inflat begin increas high-singl
digit number brand drug increas
pharmedium issu resolv sooner anticip
allow busi contribut margin
histor five-year multipl pt
gener deflat acceler high-doubl digit
brand inflat continu moder mid-singl
digit manufactur choos increas price
pharmedium facil closur extend and/or
order dont return pre-closur level facil re-
page
pleas see import disclosur inform page report
statement earn
page
pleas see import disclosur inform page report
